Vetrepharm ApS: Financial statements 2017
CVR: 15206802
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 129,186 and a net result of DKK 41,657 compared with DKK -25,566 the year before. That is an increase of 158.8% compared with the year before. Equity in the 2017 report amounted to DKK 1,119,410. The solvency ratio was 85%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 129,186
- Profit/Loss
- DKK 41,657
- Equity
- DKK 1,119,410
- Total Assets
- DKK 1,316,646
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 129 t. | 42 t. | 1.1 mio. | 1 |
| 2016 | - | 50 t. | -26 t. | 1.1 mio. | 1 |
| 2015 | - | 678 t. | 200 t. | 1.6 mio. | - |
| 2014 | - | 1.1 mio. | 510 t. | 1.4 mio. | - |
| 2013 | - | 1.1 mio. | 466 t. | 1.4 mio. | - |
Official annual report
Keep an eye on Vetrepharm ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Vetrepharm ApS has published its annual report for 2016. Gross profit came to DKK 49,915, and the net result was DKK -25,566.
About Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.